Characterization of physiologic 18f-fdg uptake with pet-ct in dogs

Veterinary Radiology and Ultrasound

Volumn 51, Issue 6, 2010, Pages 670-673

  Lee, Min Su ^a   Lee, Ah Ra ^a   Jung, Mi Ae ^a   Lee, In Hye ^a   Choi, Ji Hye ^c   Chung, Hyun Woo ^b   Jeong, Soon Wuk ^a   Nahm, Sang Soep ^a   Eom, Ki Dong ^a  

^a Konkuk University   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c Haemaru Referral Hospital   (South Korea)

Author keywords

18F FDG; Dog; PET CT; Physiologic 18F FDG uptake; SUV

Indexed keywords

CANIS FAMILIARIS;

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOG; FEMALE; MALE; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; REFERENCE VALUE;

ANIMALS; DOGS; FEMALE; FLUORODEOXYGLUCOSE F18; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERENCE VALUES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78349266862     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2010.01727.x     Document Type: Article

References (27)

1. Lamki LM. Positron emission tomography in oncology: general acceptance of its overdue. Cancer 1996;78:2039-2042.
2. Weber WA, Avril N, Schwaiger M. Relevance of positron emission tomography (PET) in oncology. Strahlenther Onkol 1999;175:356-373.
3. Blodgett TM, Meltzer CC, Townsend DW. PET/CT: form and function. Radiology 2007;242:360-385.
4. Cohade C, Wahl RL. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 2003;33:228-237.
5. Weber WA, Schwaiger M, Avril N. Quantitative assessment of tumor metabolism using FDG-PET imaging. Nucl Med Biol 2000;27:683-687.
6. Coleman RE. FDG imaging. Nucl Med Biol 2000;27:689-690.
7. Hustinx R, Bènard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 2002;32:35-46.
8. 18F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. J Clin Oncol 1999;17:3201-3206.
9. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-1839.
10. Ramos CD, Erdi YE, Gonen M, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med 2001;28:155-164.
11. Wang Y, Chiu E, Rosenberg J, et al. Standardized uptake value atlas: characterization of physiological 2-deoxy-2-[18F]fluoro-d-glucose uptake in normal tissues. Mol Imaging Biol 2007;9:83-90.
12. Engel H, Steinert H, Buck A, et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441-446.
13. Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol 2006;16:1054-1065.
14. Kostakoglu L, Hardoff R, Mirtcheva R, et al. PET/CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radio Graphics 2004;24:1411-1431.
15. Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR 1997;169:1675-1680.
16. Kim JS, Lee JS, Lee BI, et al. Performance characteristics of 3D GSO PET/CT scanner (Philips GEMINI PET/CT). Korean J Nucl Med 2004;38:318-324.
17. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 1999;354:1155-1163.
18. Patz EF Jr., Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
19. Patel AB, De Graaf RA, Mason GF, et al. Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. J Cereb Blood Flow Metab 2004;24:972-985.
20. 18F-FDG assessed by PET/CT. Vet Radiol Ultrasound 2010;51:130-135.
21. Alkire MT, Haier RJ, Shah NK, et al. Positron emission tomography study of regional cerebral metabolism in humans during isoflurane anasthesia. Anesthesiology 1997;86:549-557.
22. Goeress GW, Von Schulthess GK, Hany TF. Positron emission tomography and PET CT of the head and neck: FDG upake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR 2002;179:1337-1343.
23. Tan LTH, Ong KL. Semi-quantitative measurements of normal organs with variable metabolic activity FDG PET imaging. Ann Acad Med Singapore 2004;33:183-185.
24. Vanter SF. Effects of anesthesia on cardiovascular control mechanisms. Environ Health Perspect 1978;26:193-206.
25. Delbeke D, Martin WH, Sandler MP, et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998;133:510-516.
26. Yasuda S, Takahashi W, Takagi S, et al. Factors influencing physiological FDG uptake in the intestine. Tokai J Exp Clin Med 1998;23:241-244.
27. 18FDG) with positron emission tomography in the normal dog. Vet Radiol Ultrasound 2008;49:182-188.